Back to Search
Start Over
New pharmacologic approaches to the prevention of space/motion sickness
- Source :
- Journal of Clinical Pharmacology. 31(10)
- Publication Year :
- 1991
- Publisher :
- United States: NASA Center for Aerospace Information (CASI), 1991.
-
Abstract
- Three fundamental approaches used in the selection of new agents for the evaluation in the prevention of space-motion sickness (SMS) are reviewed, with emphasis on drugs under investigation at the Johnson Space Center. These approaches are: (1) the selection of agents from drug classes that possess pharmacologic properties of established antimotion sickness agents, (2) the selection of drugs that are used to prevent emesis caused by means other than the exposure to motion, and (3) basic research that characterizes individual differences in susceptibility to SMS. In the latter type of studies, it was found that subjects who were more resistant to SMS had higher plasma AVP after severe nausea than subjects with lower resistance. The review details the experimental data collected on AVP and adrenocorticotropin. It is noted that data support interrelated roles for AVP and opioid peptides in SMS.
- Subjects :
- Aerospace Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 00912700
- Volume :
- 31
- Issue :
- 10
- Database :
- NASA Technical Reports
- Journal :
- Journal of Clinical Pharmacology
- Notes :
- NAS9-18128, , RTOP 199-16-11-08
- Publication Type :
- Report
- Accession number :
- edsnas.19930033541
- Document Type :
- Report